This company listing is no longer active
7ME Stock Overview
A biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
METabolic EXplorer S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.095 |
| 52 Week High | €0.86 |
| 52 Week Low | €0.085 |
| Beta | 1.08 |
| 11 Month Change | 0% |
| 3 Month Change | -11.55% |
| 1 Year Change | -89.13% |
| 33 Year Change | -97.74% |
| 5 Year Change | -93.36% |
| Change since IPO | -97.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7ME | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | 0% | -1.0% | -0.02% |
| 1Y | -89.1% | -2.0% | 8.2% |
Return vs Industry: 7ME underperformed the German Chemicals industry which returned -5% over the past year.
Return vs Market: 7ME underperformed the German Market which returned -1.7% over the past year.
Price Volatility
| 7ME volatility | |
|---|---|
| 7ME Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 4.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 7ME's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 7ME's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 450 | Benjamin Gonzalez | www.metabolic-explorer.com |
METabolic EXplorer S.A., a biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. The company also offers propanediol, butyric acid, butyric acid, glycolic acid, amino acid, and L-Valine. Its products are used in the formulation of cosmetics, textiles, polymer, animal nutrition, and health products or as intermediates for the synthesis of biomaterials.
METabolic EXplorer S.A. Fundamentals Summary
| 7ME fundamental statistics | |
|---|---|
| Market cap | €6.16m |
| Earnings (TTM) | -€49.34m |
| Revenue (TTM) | €168.17m |
0.0x
P/S Ratio-0.1x
P/E RatioIs 7ME overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7ME income statement (TTM) | |
|---|---|
| Revenue | €168.17m |
| Cost of Revenue | €174.73m |
| Gross Profit | -€6.56m |
| Other Expenses | €42.78m |
| Earnings | -€49.34m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.97 |
| Gross Margin | -3.90% |
| Net Profit Margin | -29.34% |
| Debt/Equity Ratio | 122.3% |
How did 7ME perform over the long term?
See historical performance and comparison